5-Chloro-2-methoxybenzene-1-sulfonyl chloride → HCID 67365348, compound

HRID 1914156Notes

Reaction equation

HRID 1914156 reaction equation
Cl.[CH3:2][O:3][C:4]1[CH:5]=[C:6]([C:12]2[C:13]([CH3:25])([CH3:24])[C:14](=[O:23])[N:15]([CH:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)[N:16]=2)[CH:7]=[CH:8][C:9]=1[O:10][CH3:11].[Cl:26][C:27]1[CH:28]=[CH:29][C:30]([O:37][CH3:38])=[C:31]([S:33](Cl)(=[O:35])=[O:34])[CH:32]=1>>[Cl:26][C:27]1[CH:28]=[CH:29][C:30]([O:37][CH3:38])=[C:31]([S:33]([N:20]2[CH2:21][CH2:22][CH:17]([N:15]3[C:14](=[O:23])[C:13]([CH3:25])([CH3:24])[C:12]([C:6]4[CH:7]=[CH:8][C:9]([O:10][CH3:11])=[C:4]([O:3][CH3:2])[CH:5]=4)=[N:16]3)[CH2:18][CH2:19]2)(=[O:34])=[O:35])[CH:32]=1

Participants

3

Procedure

The title compound is prepared analogously as described for GP1 using 5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2-(piperidin-4-yl)-2,4-dihydro-3H-pyrazol-3-one (compound B1) and 5-chloro-2-methoxybenzenesulfonyl chloride as starting compounds. The crude product is purified by crystallization from EA and diethyl ether to yield the title compound.

Workup

  1. customThe title compound is prepared analogously
  2. customThe crude product is purified by crystallization from EA and diethyl ether

Sources & evidence

ORD record
ord-ca4e23e4bb2047ad9754a61209809a9e
Source dataset
uspto-grants-2013_12
Patent number
US08609848B2

Reaction notes

Loading…